---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-000702"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T09:25:24.669527+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience shareholders elect all six directors and ratify auditor at annual meeting

## Summary
- All six director nominees elected with 85-99% support: Bunka, Docherty, Baxter, McKechnie, Reese Jr., Turkel.
- Malone Bailey LLP ratified as auditors with 99% of votes cast.
- Ratification of directors' actions passed with 97% of votes cast.

## SEC filing metadata
- accession: 0001640334-24-000702
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000702/0001640334-24-000702-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000702/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-000702
- JSON: https://secwatch.observer/filing/0001640334-24-000702.json
- Plain text: https://secwatch.observer/filing/0001640334-24-000702.txt

## Key facts
- Shareholder Votes
  Lexaria Bioscience Corp. shareholders approved To Appoint Malone Bailey LLP as Auditors at the 2024-04-23 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-04-23
  source text: To Appoint Malone Bailey LLP as Auditors 6,566,179 59,519 39,529 0 99 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000702/0001640334-24-000702-index.htm
- Shareholder Votes
  Lexaria Bioscience Corp. shareholders approved Election of Directors at the 2024-04-23 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-04-23
  source text: To Elect Chris Bunka as a director 4,188,641 43,840 N/A 2,432,746 99 % To Elect John Docherty as a director 4,189,577 42,904 N/A 2,432,746 99 % To Elect Nicholas Baxter as a director 4,161,194 71,287 N/A 2,432,746 98 % To Elect Ted McKechnie as a director 3,735,858 496,623 N/A 2,432,746 88 % To Elect Albert Reese Jr. as a director 3,603,029 629,452 N/A 2,432,746 85 % To Elect Dr. Catherine Turkel as a director 4,181,783 50,698 N/A 2,432,746 99 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000702/0001640334-24-000702-index.htm
- Shareholder Votes
  Lexaria Bioscience Corp. shareholders approved To Ratify the lawful actions of the directors for the past year at the 2024-04-23 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-04-23
  source text: To Ratify the lawful actions of the directors for the past year 4,110,965 67,011 54,505 2,432,746 97 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000702/0001640334-24-000702-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.